Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Pulmonary Fibrosis Learning and Self-Management Program (FILIP) for patients in rehab and outpatient care

Official title: Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease - an Observational Study

Run by Insel Gruppe AG, University Hospital Bern · NCT07457463 · Data updated 2026-11-12

This study will try a blended digital education and self-management program for adults with fibrotic interstitial lung disease during pulmonary rehabilitation and outpatient ILD care to see if patients find it acceptable, practical, and linked to changes in health outcomes.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorInsel Gruppe AG, University Hospital Bern
Academic / other
Locations2 sites (Bern and 1 other locations)
StatusRecruiting
StartedOctober 7, 2025
Main results expectedAugust 2027
Study endsAugust 2027
Registry record updatedMarch 9, 2026
Trial IDNCT07457463 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with fibrotic interstitial lung disease who are able to consent, speak German, and are receiving inpatient pulmonary rehabilitation or outpatient ILD care at the participating centers are ideal candidates.

Probably not a fit

Patients with cognitive impairment, insufficient German language skills, sarcoidosis (which is excluded), or those not treated at the participating centers are unlikely to benefit from participating in this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, before-after observational cohort study implements a blended digital education and self-management program combining web-based e-learning modules with opportunities to discuss content with clinicians during routine inpatient pulmonary rehabilitation or outpatient ILD visits. A feasibility cohort receiving the program is compared to a historical control cohort treated before implementation, and an embedded feasibility sub-study examines recruitment, retention, and data collection processes. Outcomes include measures of acceptability, usability, and selected health-related outcomes collected before and after program use. The study focuses on adults with fibrotic interstitial lung disease treated at participating centers in Bern, Switzerland.

Why it matters

Potential benefit: If successful, the program could improve patients' disease knowledge, self-management skills, symptom coping, and overall quality of life.

How similar studies have gone: Similar digital and blended self-management programs have shown benefits in other chronic respiratory diseases like COPD, but evidence specifically in fibrotic ILD is limited and this approach remains relatively novel for this population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria are:

* Diagnosis of a FILD as major indication for pulmonary rehabilitation (for Berner Reha Zentrum only)
* Enrolled in Idiopathic interstitial Pneumonia (IIP) cohort study (Nr. 246/15 / PB\_2016-01524) and agreed to further use of data for further research purpose (for Inselspital only)
* Age ≥ 18 years
* Written informed consent

Exclusion criteria are:

* Cognitive inability or insufficient knowledge of project language (German) to follow informed consent or study procedures
* Sarcoidosis

Where it's running

  • Center for Rehabilitation & Sports Medicine Inselspital and Berner Reha Zentrum, Bern University Hospital, University of Bern, Switzerland
    Heiligenschwendi, Switzerland
    Recruiting
  • Department for Pulmonary Medicine, Allergology and Clinical Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
    Bern, Switzerland
    Not yet recruiting

Study contacts

  • Principal investigator: Thimo Marcin, PHD — Center for Rehabilitation & Sports Medicine Inselspital and Berner Reha Zentrum, Bern University Hospital, University of Bern, Switzerland
  • Study coordinator: Thimo Marcin, PhD
  • Email: thimo.marcin@rehabern.ch
  • Phone: +41 33 244 3048

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.